Clinical Operations

We provide end-to-end support for seamless integration of DHT in your clinical trial

Our Worldwide Experience in Supporting Clinical Trials

clinical studies

0 +

indications

0 +

satisfied clients

0 %

languages available

0 +

Geographic footprint of Syde as of January 2025

Operational Excellence Across Every Phase of Your Clinical Study

We deliver a GCP-compliant, end-to-end solution to evaluate disease progression and treatment efficacy.

Our dedicated teams manage every step, from protocol drafting to data reporting, ensuring seamless implementation regardless of patient location or sites’ technical expertise.

Our teams have the capacity to support centralized, hybrid and fully remote clinical trials.

TRIAL DESIGN AND PREPARATION

Sponsor’s Clinical Development

Sponsor’s Clinical Ops

GCP-COMPLIANT TRIAL EXECUTION

Sponsor’s Clinical Ops

CRO

Site Clinical Staff

Patient

TRIAL DATA ANALYSIS AND EXPLOITATION

Site Clinical Staff

We ensure that trials produce reliable, actionable, and regulatory-ready outcomes, that are meaningful for the patients.

Individualized Support for Your Clinical Study

At Sysnav Healthcare, each study is supported by a dedicated Study Manager committed to ensuring its success. They ensure consistent participation and data integrity through:

Real-time compliance monitoring: Day-by-day verification of the adherence of each participant.
Patient and site support: Personalized guidance for clinical teams to ensure correct and consistent use of Syde® wearable.
Proactive issue resolution: Early identification and resolution of adherence issues to maintain data continuity.

Published Evidence: Industry Studies Using the Syde Technology

Feasibility of Measuring Functional Performance of FSHD Patients Using Wearable Sensors to Quantify Physical Activity

DMD Patients Treated by SGT-001 Microdystrophin Gene Therapy Improve in the Objective Endpoint of Spontaneous Walking Velocity

Aav Gene Therapy for Duchenne Muscular Dystrophy: The Embark Phase 3 Randomized Trial

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints

Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy

Sarepta Therapeutics Announces Topline Results from EMBARK, a Global Pivotal Study of ELEVIDYS Gene Therapy for Duchenne Muscular Dystrophy

Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies

Beyond the Hype: How Wearables Can Drive Value in Drug Development

Learn how digital health technologies can transform clinical trial operations by enabling continuous, real-world patient data collection, supporting adherence, and generating actionable digital endpoints. Experts from Dyne Therapeutics, Roche, and TRINDS share insights on bridging the gap between potential and practical use in drug development.

Want to learn how we can support your clinical study?

Schedule a meeting with our team to learn more.